[Nephropathies in patients with collagen diseases].
Kawai
Shinichi
S
Division of Rheumatology, Department of Internal Medicine (Omori), Toho University School of Medicine.
D003131:Combined Modality Therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007676:Kidney Failure, Chronic / Q000209:etiology* / Q000628:therapy*; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000628:therapy; D008181:Lupus Nephritis / Q000209:etiology* / Q000628:therapy*; D008775:Methylprednisolone / Q000008:administration & dosage; D011239:Prednisolone / Q000008:administration & dosage; D020551:Pulse Therapy, Drug; D006435:Renal Dialysis; D012595:Scleroderma, Systemic / Q000150:complications* / Q000628:therapy; D014657:Vasculitis / Q000150:complications* / Q000628:therapy
D007166:Immunosuppressive Agents; D011239:Prednisolone; D008775:Methylprednisolone